Yuanbio Venture Capital

Portfolio Co Investors 2026 for Yuanbio Venture Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Yuanbio Venture Capital accounts for 5 tracked companies with verified cap-table data, 5 of which disclose round sizes totalling $239M. The median disclosed raise is $45M, and the largest is Allink Biotherapeutics at $89M, ahead of Excalipoint Therapetics ($69M) and Enzymaster ($45M).

The names that recur most often on these co-invested cap tables are Yuanbio Venture Capital (5 companies), Med-Fine Capital (3 companies), 5Y Capital (2 companies), Lanchi Ventures (1 company), Legend Capital (1 company), C&D Emerging Industry Equity Investment (1 company). By latest disclosed round, the market skews Series A (3), Seed (1), Series C (1).

Best funded Yuanbio Venture Capital companies

  1. Allink Biotherapeutics — $89M (latest: Series A)
  2. Excalipoint Therapetics — $69M (latest: Seed)
  3. Enzymaster — $45M (latest: Series C)
  4. Degron Therapeutics — $22M (latest: Series A)
  5. Reprogenix — $14M (latest: Series A)

Yuanbio Venture Capital — related firms and companies (48)

Yuanbio Venture Capital alternatives · All research reports